1. Home
  2. KTTA vs NVVE Comparison

KTTA vs NVVE Comparison

Compare KTTA & NVVE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • KTTA
  • NVVE
  • Stock Information
  • Founded
  • KTTA 2020
  • NVVE 1996
  • Country
  • KTTA United States
  • NVVE United States
  • Employees
  • KTTA 8
  • NVVE N/A
  • Industry
  • KTTA Biotechnology: Pharmaceutical Preparations
  • NVVE Oil Refining/Marketing
  • Sector
  • KTTA Health Care
  • NVVE Energy
  • Exchange
  • KTTA Nasdaq
  • NVVE Nasdaq
  • Market Cap
  • KTTA 3.4M
  • NVVE 2.8M
  • IPO Year
  • KTTA 2021
  • NVVE N/A
  • Fundamental
  • Price
  • KTTA $2.64
  • NVVE $3.00
  • Analyst Decision
  • KTTA
  • NVVE
  • Analyst Count
  • KTTA 0
  • NVVE 0
  • Target Price
  • KTTA N/A
  • NVVE N/A
  • AVG Volume (30 Days)
  • KTTA 57.9K
  • NVVE 11.6K
  • Earning Date
  • KTTA 11-13-2024
  • NVVE 11-12-2024
  • Dividend Yield
  • KTTA N/A
  • NVVE N/A
  • EPS Growth
  • KTTA N/A
  • NVVE N/A
  • EPS
  • KTTA N/A
  • NVVE N/A
  • Revenue
  • KTTA N/A
  • NVVE $5,144,831.00
  • Revenue This Year
  • KTTA N/A
  • NVVE $200.61
  • Revenue Next Year
  • KTTA N/A
  • NVVE $109.43
  • P/E Ratio
  • KTTA N/A
  • NVVE N/A
  • Revenue Growth
  • KTTA N/A
  • NVVE N/A
  • 52 Week Low
  • KTTA $2.57
  • NVVE $3.05
  • 52 Week High
  • KTTA $9.40
  • NVVE $72.70
  • Technical
  • Relative Strength Index (RSI)
  • KTTA 34.15
  • NVVE 35.57
  • Support Level
  • KTTA $2.57
  • NVVE $3.06
  • Resistance Level
  • KTTA $3.07
  • NVVE $3.69
  • Average True Range (ATR)
  • KTTA 0.21
  • NVVE 0.20
  • MACD
  • KTTA 0.01
  • NVVE -0.03
  • Stochastic Oscillator
  • KTTA 14.49
  • NVVE 5.26

About KTTA Pasithea Therapeutics Corp.

Pasithea Therapeutics Corp is a biotechnology company. It is focused on the discovery, research, and development of treatments for central nervous system (CNS) disorders and other diseases, including RASopathies. It leveraging in the fields of neuroscience, translational medicine, and drug development. Its pipeline includes Neurofibromatosis Type 1, Amyotrophic Lateral Sclerosis (ALS), Multiple Sclerosis (MS), and Schizophrenia.

About NVVE Nuvve Holding Corp.

Nuvve Holding Corp is accelerating the electrification of transportation through its proprietary vehicle-to-grid (V2G) technology. It helps to support the integration of renewable energy sources, including solar and wind. Its Grid Integrated Vehicle (GIV) platform is refueling the next generation of electric vehicle fleets through bidirectional charging solutions. It has a geographic presence in the United States, the United Kingdom, and Denmark, of which it generates the majority of its revenue in the United States.

Share on Social Networks: